Medtronic plc (MDTC34) — Capital Reinvestment Ratio
Medtronic plc (MDTC34) has a Capital Reinvestment Ratio of 0.19x as of April 2026, meaning it reinvests 0% of its operating cash flow (R$2.57 Billion) in capital expenditures (R$488.00 Million). Check Medtronic plc (MDTC34) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medtronic plc Capital Reinvestment Ratio (2019–2026)
This chart tracks Medtronic plc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Medtronic plc generate cash.
Annual Capital Reinvestment Ratio for Medtronic plc (2019–2026)
Year-by-year Capital Reinvestment Ratio for Medtronic plc from 2019 to 2026. See Medtronic plc (MDTC34) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.26x | R$7.33 Billion | R$1.90 Billion | ▼ -1.6% |
| 2025 | 0.26x | R$7.04 Billion | R$1.86 Billion | ▲ +12.9% |
| 2024 | 0.23x | R$6.79 Billion | R$1.59 Billion | ▼ -3.2% |
| 2023 | 0.24x | R$6.04 Billion | R$1.46 Billion | ▲ +29.7% |
| 2022 | 0.19x | R$7.35 Billion | R$1.37 Billion | ▼ -14.2% |
| 2021 | 0.22x | R$6.24 Billion | R$1.35 Billion | ▲ +29.5% |
| 2020 | 0.17x | R$7.23 Billion | R$1.21 Billion | ▲ +3.6% |
| 2019 | 0.16x | R$7.01 Billion | R$1.13 Billion | — |